Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zynrelef for Pain Relief Following Total Knee Arthroplasty
NCT07775248Phase 4Recruiting
- Sponsor
- Henry Ford Health
- Start
- Feb 2025
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Henry Ford Health. Started Feb 2025; status: recruiting.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07775248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775248.